International Flavors & Fragrances Inc (IFF)

International Flavors & Fragrances Inc. experienced six insider trading transactions recently, totaling approximately 2.63 million dollars in sales. These disposals occurred following an earnings report that exceeded expectations by 5.12%. The stock price has risen 11.8% over the past ninety days, currently trading near its annual peak.
Ticker: IFF Exchange: NYS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for International Flavors & Fragrances Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Teles de Mendonca Ana Paula President, Scent Officer
Transaction date
Sale
Price
174.75
Quantity 55,448 -27.1%
Value US$728,303
Transaction date
Proposed sale
Price
309.97
Quantity 22,146
Value US$200,717
Birenkrant Marc Controller & CAO Officer
Transaction date
Sale
Price
465.20
Quantity 91,323 +30.9%
Value US$1,852,605
Birenkrant Marc Officer Officer
Transaction date
Proposed sale
Price
85.00
Quantity 1,000
Value US$85,000
DeVeau Michael EVP, CFO Officer
Transaction date
Sale
Price
85.55
Quantity 8,825 -62.9%
Value US$754,970
DeVeau Michael Officer Officer
Transaction date
Proposed sale
Price
85.55
Quantity 8,825
Value US$754,969
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Purchase
Price
74.28
Quantity 260,000 +10.7%
Value US$19,312,280
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Purchase
Price
74.49
Quantity 13,500 +45.5%
Value US$1,005,574
3.1
Fyrwald J Erik Chief Executive Officer Executive Director
Transaction date
Purchase
Price
69.85
Quantity 13,360 +17.1%
Value US$933,224
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Purchase
Price
70.13
Quantity 142,000 +6.2%
Value US$9,957,963
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Purchase
Price
70.07
Quantity 14,200 +91.9%
Value US$995,015
3.1
Fyrwald J Erik Chief Executive Officer Executive Director
Transaction date
Purchase
Price
68.87
Quantity 900 +1.2%
Value US$61,980
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Purchase
Price
73.93
Quantity 3 +37.5%
Value US$222
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Purchase
Price
74.63
Quantity 146 +55.5%
Value US$10,896
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Sale
Price
63.35
Quantity 3 -27.3%
Value US$190
1.7
Landsman Stephen N EVP, General Counsel Officer
Transaction date
Purchase
Price
63.48
Quantity 3,100 +25.8%
Value US$196,788
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Sale
Price
65.27
Quantity 25 -69.4%
Value US$1,632
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Sale
Price
65.42
Quantity 187 -41.6%
Value US$12,234
3.6
Yildiz Beril Former Officer Officer
Transaction date
Proposed sale
Price
62.51
Quantity 4,060
Value US$253,810
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Purchase
Price
63.64
Quantity 39 +inf%
Value US$2,482
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Sale
Price
60.87
Quantity 7 -100.0%
Value US$426
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Purchase
Price
66.91
Quantity 71 +18.7%
Value US$4,751
3.3
FRIBOURG PAUL J Non-Executive Director
Transaction date
Purchase
Price
64.80
Quantity 15,450 +inf%
Value US$1,001,183
3.1
Fyrwald J Erik Chief Executive Officer Executive Director
Transaction date
Purchase
Price
64.95
Quantity 15,300 +24.6%
Value US$993,714
1.9
O'Byrne Kevin Non-Executive Director
Transaction date
Purchase
Price
76.05
Quantity 4,500 +140.8%
Value US$342,240
2.6
Palau Hernandez Margarita Non-Executive Director
Transaction date
Purchase
Price
77.42
Quantity 850 +55.1%
Value US$65,807
3.6
Yildiz Beril Officer Officer
Transaction date
Proposed sale
Price
77.34
Quantity 2,400
Value US$185,604
3.6
Yildiz Beril CAO, SVP & Controller Officer
Transaction date
Sale
Price
77.34
Quantity 2,400 -41.9%
Value US$185,604
1.7
Landsman Stephen N EVP, General Counsel Officer
Transaction date
Purchase
Price
77.58
Quantity 2,000 +20.0%
Value US$155,156
1.7
Landsman Stephen N EVP, General Counsel Officer
Transaction date
Purchase
Price
77.22
Quantity 10,000 +inf%
Value US$772,200
2.7
Khan Mehmood Non-Executive Director
Transaction date
Purchase
Price
75.32
Quantity 300 +7.0%
Value US$22,596
2.7
Khan Mehmood Non-Executive Director
Transaction date
Purchase
Price
75.33
Quantity 3,700 +612.6%
Value US$278,718
3.1
Fyrwald J Erik Chief Executive Officer Executive Director
Transaction date
Purchase
Price
73.97
Quantity 24,300 +64.3%
Value US$1,797,456
3.1
Fyrwald J Erik Chief Executive Officer Executive Director
Transaction date
Purchase
Price
74.00
Quantity 700 +1.9%
Value US$51,797
1.9
O'Byrne Kevin Non-Executive Director
Transaction date
Purchase
Price
80.44
Quantity 6,500 +inf%
Value US$522,833
3.1
Fyrwald J Erik CEO Executive Director
Transaction date
Purchase
Price
80.24
Quantity 25,000 +581.4%
Value US$2,005,878
2.9
Arora Yuvraj Officer Officer
Transaction date
Proposed sale
Price
91.76
Quantity 5,000
Value US$458,775
2.9
Arora Yuvraj President, Nourish Officer
Transaction date
Sale
Price
91.76
Quantity 5,000 -60.7%
Value US$458,775
1.0
Strzelecki Angela President, Pharma Solutions Officer
Transaction date
Sale
Price
95.66
Quantity 2,588 -23.3%
Value US$247,560
1.0
Strzelecki Angela Officer Officer
Transaction date
Proposed sale
Price
95.66
Quantity 2,588
Value US$247,561
2.4
Costa Mark J Non-Executive Director
Transaction date
Sale
Price
66.05
Quantity 15 -3.1%
Value US$991
2.4
Costa Mark J Non-Executive Director
Transaction date
Purchase
Price
80.95
Quantity 15 +3.2%
Value US$1,214
2.4
Costa Mark J Non-Executive Director
Transaction date
Sale
Price
77.49
Quantity 15 -3.1%
Value US$1,162
3.1
Fauchon de Villeplee Christophe President, Scent Officer
Transaction date
Sale
Price
86.35
Quantity 1,972 -17.8%
Value US$170,282
3.1
Transaction date
Proposed sale
Price
86.35
Quantity 1,972
Value US$170,282
2.4
Costa Mark J Non-Executive Director
Transaction date
Purchase
Price
84.27
Quantity 10 +inf%
Value US$843
Fortanet Francisco EVP, Operations Officer
Transaction date
Planned sale
Price
125.00
Quantity 10,000 -36.7%
Value US$1,250,000
3.1
GORDON ILENE S Non-Executive Director
Transaction date
Purchase
Price
140.39
Quantity 1,000 +392.2%
Value US$140,386
2.0
Herriott Simon President Health & Biosciences Officer
Transaction date
Sale
Price
138.47
Quantity 1,332 -46.8%
Value US$184,442
2.9
MIRZAYANTZ NICOLAS Group President Fragrance Officer
Transaction date
Planned sale
Price
118.04
Quantity 156 -0.5%
Value US$18,414
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-19 2026-08-17 S Sale

President, Scent

Officer
55,448 -27.1%
174.75
US$728,303
55,448 -27.1% 174.75 US$728,303
2026-08-17 2026-08-17 PrS Proposed sale

Officer

Officer
22,146
309.97
US$200,717
22,146 309.97 US$200,717
2026-08-10 2026-08-07 S Sale

Controller & CAO

Officer
91,323 +30.9%
465.20
US$1,852,605
91,323 +30.9% 465.20 US$1,852,605
2026-08-07 2026-08-07 PrS Proposed sale

Officer

Officer
1,000
85.00
US$85,000
1,000 85.00 US$85,000
2026-08-07 2026-08-06 S Sale

EVP, CFO

Officer
8,825 -62.9%
85.55
US$754,970
8,825 -62.9% 85.55 US$754,970
2026-08-06 2026-08-06 PrS Proposed sale

Officer

Officer
8,825
85.55
US$754,969
8,825 85.55 US$754,969
2026-06-02 2026-06-01 B Purchase Non-Executive Director
260,000 +10.7%
74.28
US$19,312,280
260,000 +10.7% 74.28 US$19,312,280
2026-06-02 2026-06-01 B Purchase Non-Executive Director
13,500 +45.5%
74.49
US$1,005,574
13,500 +45.5% 74.49 US$1,005,574
2026-03-16 2026-03-13 B Purchase

Chief Executive Officer

Executive Director
13,360 +17.1%
69.85
US$933,224
13,360 +17.1% 69.85 US$933,224
2026-03-16 2026-03-12 B Purchase Non-Executive Director
142,000 +6.2%
70.13
US$9,957,963
142,000 +6.2% 70.13 US$9,957,963
2026-03-16 2026-03-12 B Purchase Non-Executive Director
14,200 +91.9%
70.07
US$995,015
14,200 +91.9% 70.07 US$995,015
2026-03-16 2026-03-12 B Purchase

Chief Executive Officer

Executive Director
900 +1.2%
68.87
US$61,980
900 +1.2% 68.87 US$61,980
2026-03-16 2026-03-06 B Purchase Non-Executive Director
3 +37.5%
73.93
US$222
3 +37.5% 73.93 US$222
2026-03-16 2026-02-09 B Purchase Non-Executive Director
146 +55.5%
74.63
US$10,896
146 +55.5% 74.63 US$10,896
2026-03-16 2025-12-15 S Sale Non-Executive Director
3 -27.3%
63.35
US$190
3 -27.3% 63.35 US$190
2025-12-12 2025-12-12 B Purchase

EVP, General Counsel

Officer
3,100 +25.8%
63.48
US$196,788
3,100 +25.8% 63.48 US$196,788
2026-03-16 2025-12-10 S Sale Non-Executive Director
25 -69.4%
65.27
US$1,632
25 -69.4% 65.27 US$1,632
2026-03-16 2025-11-18 S Sale Non-Executive Director
187 -41.6%
65.42
US$12,234
187 -41.6% 65.42 US$12,234
2025-11-07 2025-11-07 PrS Proposed sale

Former Officer

Officer
4,060
62.51
US$253,810
4,060 62.51 US$253,810
2026-03-16 2025-10-30 B Purchase Non-Executive Director
39 +inf%
63.64
US$2,482
39 +inf% 63.64 US$2,482
2026-03-16 2025-09-29 S Sale Non-Executive Director
7 -100.0%
60.87
US$426
7 -100.0% 60.87 US$426
2026-03-16 2025-08-27 B Purchase Non-Executive Director
71 +18.7%
66.91
US$4,751
71 +18.7% 66.91 US$4,751
2025-08-08 2025-08-07 B Purchase Non-Executive Director
15,450 +inf%
64.80
US$1,001,183
15,450 +inf% 64.80 US$1,001,183
2025-08-07 2025-08-07 B Purchase

Chief Executive Officer

Executive Director
15,300 +24.6%
64.95
US$993,714
15,300 +24.6% 64.95 US$993,714
2025-05-23 2025-05-22 B Purchase Non-Executive Director
4,500 +140.8%
76.05
US$342,240
4,500 +140.8% 76.05 US$342,240
2025-05-20 2025-05-19 B Purchase Non-Executive Director
850 +55.1%
77.42
US$65,807
850 +55.1% 77.42 US$65,807
2025-05-19 2025-05-19 PrS Proposed sale

Officer

Officer
2,400
77.34
US$185,604
2,400 77.34 US$185,604
2025-05-19 2025-05-19 S Sale

CAO, SVP & Controller

Officer
2,400 -41.9%
77.34
US$185,604
2,400 -41.9% 77.34 US$185,604
2025-05-19 2025-05-19 B Purchase

EVP, General Counsel

Officer
2,000 +20.0%
77.58
US$155,156
2,000 +20.0% 77.58 US$155,156
2025-05-19 2025-05-19 B Purchase

EVP, General Counsel

Officer
10,000 +inf%
77.22
US$772,200
10,000 +inf% 77.22 US$772,200
2025-05-15 2025-05-15 B Purchase Non-Executive Director
300 +7.0%
75.32
US$22,596
300 +7.0% 75.32 US$22,596
2025-05-15 2025-05-15 B Purchase Non-Executive Director
3,700 +612.6%
75.33
US$278,718
3,700 +612.6% 75.33 US$278,718
2025-05-09 2025-05-09 B Purchase

Chief Executive Officer

Executive Director
24,300 +64.3%
73.97
US$1,797,456
24,300 +64.3% 73.97 US$1,797,456
2025-05-09 2025-05-08 B Purchase

Chief Executive Officer

Executive Director
700 +1.9%
74.00
US$51,797
700 +1.9% 74.00 US$51,797
2025-03-06 2025-03-05 B Purchase Non-Executive Director
6,500 +inf%
80.44
US$522,833
6,500 +inf% 80.44 US$522,833
2025-03-05 2025-03-04 B Purchase

CEO

Executive Director
25,000 +581.4%
80.24
US$2,005,878
25,000 +581.4% 80.24 US$2,005,878
2024-11-12 2024-11-11 PrS Proposed sale

Officer

Officer
5,000
91.76
US$458,775
5,000 91.76 US$458,775
2024-11-12 2024-11-11 S Sale

President, Nourish

Officer
5,000 -60.7%
91.76
US$458,775
5,000 -60.7% 91.76 US$458,775
2024-06-14 2024-06-13 S Sale

President, Pharma Solutions

Officer
2,588 -23.3%
95.66
US$247,560
2,588 -23.3% 95.66 US$247,560
2024-06-13 2024-06-13 PrS Proposed sale

Officer

Officer
2,588
95.66
US$247,561
2,588 95.66 US$247,561
2026-03-25 2023-10-25 S Sale Non-Executive Director
15 -3.1%
66.05
US$991
15 -3.1% 66.05 US$991
2026-03-25 2023-08-04 B Purchase Non-Executive Director
15 +3.2%
80.95
US$1,214
15 +3.2% 80.95 US$1,214
2026-03-25 2023-05-30 S Sale Non-Executive Director
15 -3.1%
77.49
US$1,162
15 -3.1% 77.49 US$1,162
2023-05-12 2023-05-11 S Sale

President, Scent

Officer
1,972 -17.8%
86.35
US$170,282
1,972 -17.8% 86.35 US$170,282
2023-05-11 2023-05-11 PrS Proposed sale

Officer

Officer
1,972
86.35
US$170,282
1,972 86.35 US$170,282
2026-03-25 2023-03-24 B Purchase Non-Executive Director
10 +inf%
84.27
US$843
10 +inf% 84.27 US$843
2022-08-15 2022-08-11 PlS Planned sale

EVP, Operations

Officer
10,000 -36.7%
125.00
US$1,250,000
10,000 -36.7% 125.00 US$1,250,000
2022-06-02 2022-06-01 PlS Planned sale

President, Scent

Officer
629 -7.1%
132.59
US$83,399
629 -7.1% 132.59 US$83,399
2022-05-03 2022-05-02 PlS Planned sale

President, Scent

Officer
630 -6.7%
121.68
US$76,658
630 -6.7% 121.68 US$76,658
2021-05-17 2021-05-14 B Purchase Non-Executive Director
1,000 +392.2%
140.39
US$140,386
1,000 +392.2% 140.39 US$140,386
2021-05-17 2021-05-13 S Sale

President Health & Biosciences

Officer
1,332 -46.8%
138.47
US$184,442
1,332 -46.8% 138.47 US$184,442
2020-04-17 2020-04-16 PlS Planned sale

Group President Fragrance

Officer
156 -0.5%
118.04
US$18,414
156 -0.5% 118.04 US$18,414
2020-04-01 2020-03-30 B Purchase Large shareholder
100 +0.0%
112.78
US$11,278
100 +0.0% 112.78 US$11,278
2020-04-01 2020-03-30 B Purchase Large shareholder
2,100 +0.0%
111.92
US$235,032
2,100 +0.0% 111.92 US$235,032
2020-04-01 2020-03-30 B Purchase Large shareholder
6,392 +0.0%
111.25
US$711,110
6,392 +0.0% 111.25 US$711,110
2020-04-01 2020-03-30 B Purchase Large shareholder
900 +0.0%
110.04
US$99,036
900 +0.0% 110.04 US$99,036
2020-03-31 2020-03-27 B Purchase Large shareholder
3,200 +0.0%
112.76
US$360,832
3,200 +0.0% 112.76 US$360,832
2020-03-31 2020-03-27 B Purchase Large shareholder
15,100 +0.1%
111.93
US$1,690,143
15,100 +0.1% 111.93 US$1,690,143
2020-03-31 2020-03-27 B Purchase Large shareholder
16,689 +0.1%
110.99
US$1,852,312
16,689 +0.1% 110.99 US$1,852,312
2020-03-31 2020-03-27 B Purchase Large shareholder
18,817 +0.1%
110.14
US$2,072,504
18,817 +0.1% 110.14 US$2,072,504
2020-03-30 2020-03-26 B Purchase Large shareholder
2,911 +0.0%
114.02
US$331,912
2,911 +0.0% 114.02 US$331,912
2020-03-30 2020-03-26 B Purchase Large shareholder
7,789 +0.0%
113.62
US$884,986
7,789 +0.0% 113.62 US$884,986
2020-03-30 2020-03-26 B Purchase Large shareholder
8,012 +0.0%
112.42
US$900,709
8,012 +0.0% 112.42 US$900,709
2020-03-30 2020-03-26 B Purchase Large shareholder
10,900 +0.0%
111.52
US$1,215,568
10,900 +0.0% 111.52 US$1,215,568
2020-03-30 2020-03-26 B Purchase Large shareholder
2,500 +0.0%
110.42
US$276,050
2,500 +0.0% 110.42 US$276,050
2020-03-30 2020-03-26 B Purchase Large shareholder
8,201 +0.0%
109.47
US$897,763
8,201 +0.0% 109.47 US$897,763
2020-03-30 2020-03-26 B Purchase Large shareholder
5,223 +0.0%
108.38
US$566,069
5,223 +0.0% 108.38 US$566,069
2020-03-30 2020-03-26 B Purchase Large shareholder
2,700 +0.0%
107.43
US$290,061
2,700 +0.0% 107.43 US$290,061
2020-03-30 2020-03-26 B Purchase Large shareholder
1,300 +0.0%
106.04
US$137,852
1,300 +0.0% 106.04 US$137,852
2020-03-30 2020-03-26 B Purchase Large shareholder
500 +0.0%
104.87
US$52,435
500 +0.0% 104.87 US$52,435
2020-03-27 2020-03-25 B Purchase Large shareholder
100 +0.0%
108.45
US$10,845
100 +0.0% 108.45 US$10,845
2020-03-27 2020-03-25 B Purchase Large shareholder
1,700 +0.0%
107.73
US$183,141
1,700 +0.0% 107.73 US$183,141
2020-03-27 2020-03-25 B Purchase Large shareholder
10,500 +0.0%
106.64
US$1,119,720
10,500 +0.0% 106.64 US$1,119,720
2020-03-27 2020-03-25 B Purchase Large shareholder
37,220 +0.2%
105.80
US$3,937,876
37,220 +0.2% 105.80 US$3,937,876
2020-03-27 2020-03-25 B Purchase Large shareholder
23,150 +0.1%
104.87
US$2,427,740
23,150 +0.1% 104.87 US$2,427,740